Core Viewpoint - Future Wearable Health Technology Co., Ltd. has submitted its IPO application to the Hong Kong Stock Exchange, focusing on the consumerization of medical technology in the smart wearable health device sector, while facing challenges such as a sudden dividend payout and business transformation pressures [1][15]. Business Overview - Future Wearable has been in the smart wearable health device industry since 2007, establishing its core focus in 2016. The company aims to integrate professional medical technology into daily health management [2]. - The company has developed a product matrix that includes smart soothing wearable devices, which are its core business. However, this segment is experiencing a growth bottleneck, with projected revenue of 856 million yuan in 2024, a decrease of 3.7% year-on-year [2][11]. Financial Performance - From 2022 to 2024, the company's revenue was 904 million yuan, 1.046 billion yuan, and 1.045 billion yuan, respectively. For the first nine months of 2025, revenue reached 878 million yuan, a year-on-year increase of 16.2% [6]. - The net profit for the same period was 119 million yuan, 127 million yuan, and 135 million yuan, with a net profit of 106 million yuan for the first nine months of 2025, reflecting a 25% year-on-year growth [6]. - The gross margin from 2022 to 2024 was 50.4%, 49.1%, and 48.9%, with a recovery to 50.2% in the first nine months of 2025, indicating strong pricing power and technological value [6]. Market Position - According to Frost & Sullivan, Future Wearable holds a 21.5% market share in China's smart soothing wearable device market and a 4.1% share globally, ranking first in both markets [4][5]. - The company has led the drafting of national standards for low-frequency massagers and holds 1,501 registered patents, including 261 invention patents [4]. Growth Drivers - The recovery and shaping equipment segment has become a significant revenue growth driver, achieving 200 million yuan in revenue for the first three quarters of 2025, a 123% year-on-year increase [4]. - The global market for smart wearable health devices is projected to grow from 41.7 billion USD in 2024 to 79.5 billion USD by 2029, with a compound annual growth rate of 13.8% [11]. Challenges - The company relies heavily on distribution channels, with 82.7% of revenue coming from distributors as of the first nine months of 2025, raising concerns about operational control and potential revenue stability risks [7]. - A sudden dividend payout of 199 million yuan in 2025 has raised questions about the company's financial management and its ability to fund business expansion [9]. - The competitive landscape is fragmented, with the top five companies holding only 13.5% of the market share, leading to increased competition and potential pricing pressures [14].

Core Viewpoint - Future Wearable Health Technology Co., Ltd. has submitted its IPO application to the Hong Kong Stock Exchange, focusing on the smart wearable health device sector, while facing challenges such as a sudden dividend payout and business transformation pressures [1] Business Overview - Future Wearable has been in the smart wearable health device industry since 2007, establishing its core focus in 2016, and aims to integrate professional medical technology into daily health management [2] - The company has developed a product matrix covering various health needs, with its core business being smart soothing wearable devices, which are experiencing a growth bottleneck [2] - Revenue from the core business is projected to decline by 3.7% to 856 million yuan in 2024, with a revenue share dropping from 85.3% in 2023 to 72.5% in 2025 [2] Financial Performance - Future Wearable's revenue and profit have shown steady growth, with revenues of 904 million yuan in 2022, 1.046 billion yuan in 2023, and 1.045 billion yuan in 2024, while achieving 878 million yuan in the first nine months of 2025, a 16.2% increase [6] - The net profit for the same periods was 119 million yuan, 127 million yuan, and 135 million yuan, with 106 million yuan in the first nine months of 2025, reflecting a 25% increase [6] - The gross margin has remained above the industry average, with a recovery to 50.2% in the first nine months of 2025, indicating strong pricing power and technological value [6] Market Position - Future Wearable holds a leading position in the Chinese smart soothing wearable device market with a 21.5% market share by GMV in 2024, and a global market share of 4.1% [4] - The company has established itself as a standard setter in the industry, leading the drafting of national standards for home-use low-frequency massagers [4] Growth Drivers - The recovery and shaping equipment segment has become a significant revenue growth driver, achieving 200 million yuan in revenue in the first three quarters of 2025, a 123% increase [4] - The global market for smart wearable health devices is projected to grow from 41.7 billion USD in 2024 to 79.5 billion USD by 2029, with a compound annual growth rate of 13.8% [11] Challenges and Risks - The company relies heavily on a concentrated distribution channel, with 82.7% of revenue coming from distributors as of September 2025, raising concerns about operational control and potential revenue stability risks [7] - A sudden dividend payout of 199 million yuan before the IPO has raised questions about the company's financial management and liquidity, with a significant increase in interest-bearing bank loans from 173,000 yuan in 2022 to 1.8 billion yuan by September 2025 [9] - The competitive landscape is fragmented, with the top five companies holding only 13.5% of the market share, leading to increased pricing pressure and potential market share erosion [14]

Core Viewpoint - After two unsuccessful attempts to list on the A-share market, the parent company of SKG, Future Wearable Technology Co., Ltd., has turned its attention to the Hong Kong stock market by submitting its IPO application to the Hong Kong Stock Exchange [1][3]. Group 1: Company Performance - Future Wearable has shown steady growth in net profit for the first three quarters of 2023, 2024, and 2025 [1]. - The company achieved revenues of approximately 9.04 billion, 10.46 billion, and 10.45 billion for the years 2022, 2023, and 2024, respectively, with corresponding net profits of about 1.19 billion, 1.27 billion, and 1.35 billion [3]. - For the first three quarters of 2025, the company reported revenues of approximately 8.78 billion and a net profit of about 1.06 billion, both showing year-on-year growth [3]. Group 2: Product and Market Position - Future Wearable ranks first in China's smart soothing wearable device industry, with a projected market share of 21.5% in 2024 [3]. - The product matrix includes smart soothing wearable devices, fitness recovery and shaping devices, smart health watches, and health home products, with sales figures for the first three quarters of this year being approximately 6.3 billion, 2 billion, 553.1 million, and 340.18 million, respectively [3]. Group 3: Financial Strategy and Concerns - The company has been criticized for its heavy marketing and light R&D approach, with sales and marketing expenses rising while R&D costs have decreased [6]. - In the first three quarters of this year, the company's sales and marketing expenses were approximately 1.98 billion, which is 3.4 times the R&D costs of 581 million [7]. - The company declared a significant dividend of 1.99 billion for the first three quarters, which accounted for 187.74% of its net profit during that period [8]. Group 4: Corporate Governance and Control - The controlling shareholders, including Liu Jie, Xu Siying, and others, hold approximately 85.94% of the voting rights due to a concerted action arrangement [9].

Core Viewpoint - After two unsuccessful attempts to list on A-shares, the parent company of SKG, Future Wearable Technology Co., Ltd., has turned its attention to the Hong Kong stock market by submitting its IPO application to the Hong Kong Stock Exchange [1][3]. Financial Performance - Future Wearable's revenue for 2022, 2023, and 2024 is approximately RMB 904.23 million, RMB 1.05 billion, and RMB 1.04 billion respectively, with corresponding net profits of about RMB 119 million, RMB 127 million, and RMB 135 million [2][3]. - For the first three quarters of 2025, the company reported revenue of approximately RMB 878 million and a net profit of about RMB 106 million, showing year-on-year growth in both revenue and net profit [3]. Marketing and R&D Expenditure - Sales and marketing expenses have been increasing, accounting for 18.2%, 20.6%, 21.6%, and 22.6% of total revenue from 2022 to the first three quarters of 2025 [5][6]. - In contrast, R&D costs have decreased, representing 9.1%, 9.1%, 7.6%, and 6.6% of revenue during the same periods [6][7]. Dividend Distribution - In the first three quarters of this year, Future Wearable declared dividends totaling RMB 199 million, which is 187.74% of its net profit for the period [1][8]. - The company also distributed dividends of RMB 50 million and RMB 30 million in 2022 and 2023, respectively, which accounted for approximately 42.02% and 23.62% of net profits for those years [8]. Market Position and Product Categories - Future Wearable ranks first in China's smart soothing wearable device industry, with a projected market share of 21.5% in 2024 [3]. - For the first three quarters of this year, the sales breakdown by product category includes approximately RMB 630 million from smart soothing wearable devices, RMB 200 million from fitness recovery and shaping devices, RMB 5.53 million from smart health watches, and RMB 34.02 million from health home products [3].

Core Viewpoint - Future Health Technology Co., Ltd. (referred to as "Future Health" or "SKG") has faced multiple setbacks in its attempts to go public, raising questions about its sincerity and business model as it prepares for its third IPO attempt after withdrawing its application from the ChiNext and terminating its North Exchange guidance [1][2]. Group 1: Financial Performance and Challenges - SKG's core product, the "smart soothing wearable device," has seen stagnant revenue growth, with income of 630 million yuan in the first three quarters of 2025, reflecting only a 0.2% year-on-year increase [3][4]. - The company's total revenue grew by 16.22% to 878 million yuan in the first nine months of 2025, but the core product's revenue growth has stalled, indicating a potential decline in consumer demand [3][4]. - SKG's cumulative dividends reached 280 million yuan, accounting for 74% of its net profit during the reporting period, raising concerns about its financial management and intentions [7][9]. Group 2: Marketing and Consumer Complaints - Despite a decline in revenue, SKG has maintained high marketing expenditures, with sales expenses in the first nine months of 2025 reaching 22.6% of total revenue, significantly higher than industry standards [10][12]. - The company has faced over 300 complaints regarding product quality and safety, with issues such as severe burns and pricing discrepancies being highlighted by consumers [15][17]. - SKG's after-sales service has been criticized for inefficiency, with consumers reporting difficulties in resolving product issues, which may undermine the brand's long-term reputation [18]. Group 3: Research and Development - SKG's investment in research and development has decreased, with R&D expenditure as a percentage of revenue falling from 9.1% in 2022 to 6.6% by the end of September 2025, contradicting its claims of being a technology-driven company [10][12]. - The company's focus on marketing over product development raises concerns about its ability to sustain growth and innovation in a competitive market [10][12].

Core Viewpoint - SKG is a leading company in the smart wearable health device sector, focusing on integrating professional medical technology into consumer electronics to enhance health management and redefine health experiences [3][4]. Company Overview - SKG has been dedicated to the smart wearable health device field since 2016 and has established itself as a leader in both China and globally [3]. - The company offers a diverse product matrix, including smart soothing wearable devices, post-exercise recovery and shaping devices, smart health watches, and health home products [3]. - SKG's innovative applications of medical technologies such as medium-frequency pulse and transcutaneous electrical nerve stimulation (TENS) have set industry precedents [3]. Market Position - According to Frost & Sullivan, SKG holds the top position in China's smart soothing wearable device market with a projected market share of 21.5% in 2024 [3][11]. - The global smart wearable health device market reached USD 41.7 billion in 2024, expected to grow to USD 79.5 billion by 2029, with a compound annual growth rate (CAGR) of 13.8% [10]. - The Chinese market for smart wearable health devices is projected to grow from RMB 30.9 billion in 2019 to RMB 61.5 billion in 2024, with a CAGR of 14.7% [10]. Financial Performance - SKG's total revenue for 2022, 2023, and 2024 was RMB 904 million, RMB 1.046 billion, and RMB 1.045 billion, respectively, with a net profit increasing from RMB 119 million in 2022 to RMB 136 million in 2024 [7]. - The company's gross profit for the same years was RMB 456 million, RMB 514 million, and RMB 510 million, with gross margins of 50.4%, 49.1%, and 48.9% respectively [7]. - Adjusted net profit figures were RMB 137 million, RMB 123 million, and RMB 126 million for 2022, 2023, and 2024 [8]. Innovation and Patents - As of September 30, 2025, SKG holds 1,501 registered patents globally, including 261 authorized invention patents, and has submitted over 480 pending patent applications [4]. - The company has received international recognition for its innovative designs, including awards such as the Red Dot Design Award and the Hannover Industrial Design Award [4]. Future Plans - SKG plans to use the proceeds from its Hong Kong IPO to enhance its research and development capabilities in health technology, accelerate technological innovation, integrate upstream and downstream resources, and strengthen brand recognition through marketing [11].

Core Viewpoint - Future Wearable has submitted an application for listing on the Hong Kong Stock Exchange, with CITIC Securities International as the sole sponsor [1] Company Summary - Future Wearable holds a 21.5% market share in China's smart soothing wearable device market in 2024, ranking first among domestic companies [1] - The company also ranks first globally in the smart soothing wearable device market with a 4.1% market share [1] - Since 2016, the company has focused on smart wearable health devices, utilizing innovative medical-grade technologies such as medium-frequency pulse and transcutaneous electrical nerve stimulation (TENS) [1] - The product offerings include diverse smart soothing wearable devices, post-exercise recovery and shaping devices, smart health watches, and health home products [1] Industry Summary - The global smart wearable health device market is projected to grow from $41.7 billion in 2024 to $79.5 billion by 2029, with a compound annual growth rate (CAGR) of 13.8% [1] - The Chinese market is expected to increase from 615 billion RMB in 2024 to 1,283 billion RMB by 2029, with a CAGR of 15.9% [1]

Core Viewpoint - Future Wearable Health Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities International as the sole sponsor [1]. Company Overview - Future Wearable has been focused on the smart wearable health device sector since 2016 and has become a leader in the industry, integrating professional medical technology into consumer electronics to simplify health management [3]. - The company offers a diverse product matrix, including smart soothing wearable devices, recovery and shaping equipment, smart health watches, and health home products, aimed at enhancing daily health and quality of life [3][4]. - The company is actively involved in setting industry standards, having led the drafting of national standards for low-frequency massagers, contributing to the standardization of the smart soothing wearable device industry in China [3]. Market Position - According to Frost & Sullivan, Future Wearable ranks first in China's smart soothing wearable device market with a projected market share of 21.5% in 2024, and it also holds a 4.1% share in the global market [5]. - The global smart soothing wearable device market is characterized by a relatively fragmented competitive landscape, while the Chinese market has a slightly higher concentration [5]. Financial Performance - The company's revenue for the fiscal years 2022, 2023, 2024, and the nine months ending September 30, 2025, were approximately RMB 904 million, RMB 1,046 million, RMB 1,045 million, and RMB 879 million, respectively [6]. - The profit figures for the same periods were approximately RMB 119 million, RMB 127 million, RMB 135 million, and RMB 106 million [7]. - The gross profit margins for these years were 50.4%, 49.1%, 48.9%, and 50.2%, respectively [8]. Industry Overview - The global smart wearable health device market was valued at USD 22.6 billion in 2019 and is expected to grow to USD 41.7 billion by 2024, with a compound annual growth rate (CAGR) of 13.0% from 2019 to 2024 [10]. - The Chinese smart wearable health device market is projected to grow from RMB 30.9 billion in 2019 to RMB 61.5 billion by 2024, with a CAGR of 14.7% [14]. - The demand for smart wearable health devices is driven by the increasing prevalence of chronic diseases and the growing need for proactive health management solutions [10][14].

Company Overview - Future Wearable Health Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities International as the sole sponsor [1] - The company has been focused on the smart wearable health device sector since 2016 and has become a leader in the industry, integrating professional medical technology into consumer electronics [3][4] - The company offers a diverse product matrix, including smart soothing wearable devices, recovery and shaping equipment, smart health watches, and health home products, aimed at enhancing daily health and quality of life [3][4] Market Position - According to Frost & Sullivan, the company ranks first in China's smart soothing wearable device market with a projected market share of 21.5% in 2024 [3][5] - The global smart soothing wearable device market is competitive but relatively fragmented, with the company holding a 4.1% market share, making it the leader in this segment as well [5] Financial Performance - The company's revenue for the fiscal years 2022, 2023, 2024, and the nine months ending September 30, 2025, were approximately RMB 904 million, RMB 1,046 million, RMB 1,045 million, and RMB 878 million respectively [6] - The profit figures for the same periods were approximately RMB 119 million, RMB 127 million, RMB 135 million, and RMB 106 million [7] - The gross profit margins for these years were 50.4%, 49.1%, 48.9%, and 50.2% respectively [8] Industry Overview - The global smart wearable health device market was valued at USD 22.6 billion in 2019 and is expected to grow to USD 41.7 billion by 2024, with a compound annual growth rate (CAGR) of 13.0% from 2019 to 2024 [10] - The Chinese smart wearable health device market is projected to grow from RMB 30.9 billion in 2019 to RMB 61.5 billion by 2024, with a CAGR of 14.7% [14] - The demand for smart wearable health devices is driven by the increasing prevalence of chronic diseases and the growing need for proactive health management solutions [10][14]

Core Viewpoint - Future Wearable Health Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities International as the sole sponsor [1] Group 1: Market Position - The company ranks first in China's smart soothing wearable device industry by GMV and is projected to capture 21.5% of the domestic market share in 2024 [1] Group 2: Product Offering - The company has developed a diversified product matrix that includes smart soothing wearable devices, post-exercise recovery and shaping devices, smart health watches, and health home products [1] - The company aims to enhance customers' daily health and quality of life through its innovative products [1] Group 3: Technological Innovation - Several of the company's products are industry pioneers, utilizing innovative applications of medium-frequency pulse and transcutaneous electrical nerve stimulation (TENS), which are widely used in the medical field [1]